Free Trial

This company has been marked as potentially delisted and may not be actively trading.

NASDAQ:EXAC

Exactech (EXAC) Stock Price, News & Analysis

Exactech logo

About Exactech Stock (NASDAQ:EXAC)

Advanced Chart

Key Stats

Today's Range
$49.25
$49.30
50-Day Range
N/A
52-Week Range
$23.75
$50.95
Volume
255,640 shs
Average Volume
182,742 shs
Market Capitalization
N/A
P/E Ratio
N/A
Dividend Yield
N/A
Price Target
N/A
Consensus Rating
N/A

Company Overview

Exactech, Inc. develops, manufactures, markets, distributes and sells orthopedic implant devices, related surgical instrumentation and biologic services to hospitals and physicians. The Company's segments include knee, hip, biologics and spine, extremity and other products. Its other products segment includes miscellaneous sales categories, such as bone cement, instrument rental fees, shipping charges and other product lines. The Company distributes joint replacement systems, including knee, hip, spine and extremity implant systems, and biologic products and services and bone cement materials used in orthopedic surgery and dental procedures. The Exactech Knee System provides solutions for partial, primary and revision total knee arthroplasty. Its hip solutions address the continuum of hip arthroplasty. It manufactures and distributes various products and services designed for the healing and regeneration of bone and soft tissue, including products, which contain human allograft.

Receive EXAC Stock News and Ratings via Email

Sign-up to receive the latest news and ratings for Exactech and its competitors with MarketBeat's FREE daily newsletter.

EXAC Stock News Headlines

Trump wipes out trillions overnight…
Is there anybody more powerful than Donald Trump right now? In a single tariff announcement, he wiped out nearly $5 trillion in wealth from the S&P 500 and $6.4 trillion from the Dow Jones… Not to mention the countless trillions of dollars lost in every market around the world… leaving the major political powers scrambling in fear of Trump’s next move.
See More Headlines

EXAC Stock Analysis - Frequently Asked Questions

Exactech Inc (NASDAQ:EXAC) announced its earnings results on Monday, October, 30th. The medical equipment provider reported $0.20 earnings per share for the quarter, missing the consensus estimate of $0.23 by $0.03. The medical equipment provider had revenue of $61.40 million for the quarter, compared to analyst estimates of $61.78 million.

Based on aggregate information from My MarketBeat watchlists, some other companies that Exactech investors own include Immersion (IMMR), Verizon Communications (VZ), Bristol Myers Squibb (BMY), Johnson & Johnson (JNJ), Meta Platforms (META), Riot Platforms (RIOT) and Allergan (AGN).

Company Calendar

Last Earnings
10/30/2017
Today
6/23/2025

Industry, Sector and Symbol

Stock Exchange
NASDAQ
Sector
N/A
Industry
N/A
Sub-Industry
Health Care Equipment
Current Symbol
NASDAQ:EXAC
Fax
N/A
Employees
N/A
Year Founded
N/A

Profitability

Trailing P/E Ratio
N/A
Forward P/E Ratio
N/A
P/E Growth
N/A
Pretax Margin
N/A

Debt

Sales & Book Value

Annual Sales
N/A
Price / Cash Flow
N/A
Price / Book
N/A

Miscellaneous

Free Float
N/A
Optionable
Not Optionable
Beta
N/A
20 High-Yield Dividend Stocks that Could Ruin Your Retirement Cover

Almost everyone loves strong dividend-paying stocks, but high yields can signal danger. Discover 20 high-yield dividend stocks paying an unsustainably large percentage of their earnings. Enter your email to get this report and avoid a high-yield dividend trap.

Get This Free Report

This page (NASDAQ:EXAC) was last updated on 6/23/2025 by MarketBeat.com Staff
From Our Partners